Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | hydroxysteroid (17-beta) dehydrogenase 10 | Starlite/ChEMBL | No references |
Rattus norvegicus | Thioredoxin reductase 1, cytoplasmic | Starlite/ChEMBL | No references |
Homo sapiens | neuropeptide S receptor 1 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0283 | 0.0527 | 0.4254 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0077 | 0.0077 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.013 | 0.0194 | 0.0185 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0042 | 0.0336 |
Leishmania major | UDP-galactopyranose mutase | 0.0609 | 0.1238 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0145 | 0.0226 | 0.0221 |
Plasmodium vivax | hypothetical protein, conserved | 0.0609 | 0.1238 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0145 | 0.0226 | 0.0221 |
Loa Loa (eye worm) | hypothetical protein | 0.0609 | 0.1238 | 1 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0609 | 0.1238 | 1 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0069 | 0.0061 | 0.0496 |
Schistosoma mansoni | amine oxidase | 0.0609 | 0.1238 | 0.1238 |
Loa Loa (eye worm) | hypothetical protein | 0.0609 | 0.1238 | 1 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0609 | 0.1238 | 0.1393 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0145 | 0.0226 | 0.0221 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0069 | 0.0061 | 0.0031 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0609 | 0.1238 | 0.1393 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0057 | 0.0035 | 0.0281 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0077 | 0.0077 |
Brugia malayi | SWIRM domain containing protein | 0.0609 | 0.1238 | 1 |
Onchocerca volvulus | 0.0609 | 0.1238 | 0.5 | |
Trypanosoma brucei | trypanothione reductase | 0.0057 | 0.0035 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0609 | 0.1238 | 1 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.4626 | 1 | 1 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.056 | 0.1133 | 0.1102 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0069 | 0.0061 | 0.0061 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.0077 | 0.0623 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0084 | 0.0093 | 0.0093 |
Brugia malayi | Thioredoxin reductase | 0.0057 | 0.0035 | 0.0281 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0609 | 0.1238 | 0.1184 |
Mycobacterium ulcerans | oxidoreductase | 0.0609 | 0.1238 | 0.1184 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.0077 | 0.0042 |
Mycobacterium tuberculosis | Probable protoporphyrinogen oxidase HemY (protoporphyrinogen-IX oxidase) (protoporphyrinogenase) (PPO) | 0.4017 | 0.8672 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0609 | 0.1238 | 1 |
Echinococcus granulosus | neuropeptide s receptor | 0.056 | 0.1133 | 0.1271 |
Brugia malayi | glutathione reductase | 0.0057 | 0.0035 | 0.0281 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0609 | 0.1238 | 1 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0609 | 0.1238 | 0.1207 |
Brugia malayi | hypothetical protein | 0.0609 | 0.1238 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0609 | 0.1238 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0145 | 0.0226 | 0.0032 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.0077 | 0.0049 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.4626 | 1 | 1 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0609 | 0.1238 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.013 | 0.0194 | 0.0185 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.4626 | 1 | 1 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0076 | 0.0076 | 0.0041 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0084 | 0.0093 | 0.0067 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0609 | 0.1238 | 1 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0065 | 0.0051 | 0.0413 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0609 | 0.1238 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0057 | 0.0035 | 0.0281 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0609 | 0.1238 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0609 | 0.1238 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.0077 | 0.0623 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0069 | 0.0061 | 0.0027 |
Mycobacterium ulcerans | dehydrogenase | 0.0609 | 0.1238 | 0.1184 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.013 | 0.0194 | 0.0185 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0069 | 0.0061 | 0.0221 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.056 | 0.1133 | 0.1271 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.0077 | 0.0623 |
Echinococcus multilocularis | 0.0609 | 0.1238 | 0.1207 | |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0042 | 0.0336 |
Mycobacterium tuberculosis | Probable reductase | 0.013 | 0.0194 | 0.0185 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0042 | 0.0336 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.0077 | 0.0623 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0609 | 0.1238 | 0.1184 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0609 | 0.1238 | 0.1238 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0609 | 0.1238 | 1 |
Schistosoma mansoni | amine oxidase | 0.0609 | 0.1238 | 0.1238 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0069 | 0.0061 | 0.0031 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0609 | 0.1238 | 0.1393 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.013 | 0.0194 | 0.0185 |
Mycobacterium ulcerans | monoamine oxidase | 0.0609 | 0.1238 | 0.1184 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.4626 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0077 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0609 | 0.1238 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0609 | 0.1238 | 1 |
Brugia malayi | follicle stimulating hormone receptor | 0.0283 | 0.0527 | 0.4254 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0609 | 0.1238 | 0.1393 |
Echinococcus multilocularis | neuropeptide s receptor | 0.056 | 0.1133 | 0.1102 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.0077 | 0.0623 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0077 | 0.0077 |
Brugia malayi | RNA binding protein | 0.0076 | 0.0077 | 0.0623 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0609 | 0.1238 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.013 | 0.0194 | 0.0185 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0609 | 0.1238 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0077 | 0.0077 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0042 | 0.0336 |
Echinococcus granulosus | protoporphyrinogen oxidase | 0.4017 | 0.8672 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 30.1313 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.